[1]
Faiza Ahmed et al. 2025. Zanidatamab in HER2-Positive Biliary Tract Cancer: A First Narrative Literature Review. Journal of Medical Health Research and Psychiatry. 2, 2 (Oct. 2025), 1–4. DOI:https://doi.org/10.70844/jmhrp.2025.2.2.44.